More Like this

1. Effects of organic sulfur and arsenite/dissolved organic matter ratios on arsenite complexation with dissolved organic matter

   https://doi.org/10.1016/j.chemosphere.2022.134770  

   Abu-Ali, Lena; Yoon, Hyun; Reid, Matthew C. (September 2022, Chemosphere)
2. Anisotropic organic glasses

   https://doi.org/10.1016/j.cossms.2017.11.001  

   Gujral, Ankit; Yu, Lian; Ediger, M.D. (April 2018, Current Opinion in Solid State and Materials Science)
3. Doped Organic Transistors

   https://doi.org/10.1021/acs.chemrev.6b00329  

   Lüssem, Björn; Keum, Chang-Min; Kasemann, Daniel; Naab, Ben; Bao, Zhenan; Leo, Karl (October 2016, Chemical Reviews)
4. Organic amendments change soil organic C structure and microbial community but not total organic matter on sub-decadal scales

   https://doi.org/10.1016/j.soilbio.2020.107986  

   Xu, Jiangbing; Roley, Sarah S.; Tfaily, Malak M.; Chu, Rosalie K.; Tiedje, James M. (November 2020, Soil Biology and Biochemistry)

   null (Ed.)
5. Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors

   https://doi.org/10.1039/C9OB02682G  

   Minus, Matthew B.; Wang, Haopei; Munoz, Jaime O.; Stevens, Alexandra M.; Mangubat-Medina, Alicia E.; Krueger, Michael J.; Liu, Wei; Kasembeli, Moses M.; Cooper, Julian C.; Kolosov, Mikhail I.; et al (May 2020, Organic & Biomolecular Chemistry)

   Recurrence and drug resistance are major challenges in the treatment of acute myeloid leukemia (AML) that spur efforts to identify new clinical targets and active agents. STAT3 has emerged as a potential target in resistant AML, but inhibiting STAT3 function has proven challenging. This paper describes synthetic studies and biological assays for a naphthalene sulfonamide inhibitor class of molecules that inhibit G-CSF-induced STAT3 phosphorylation in cellulo and induce apoptosis in AML cells. We describe two different approaches to inhibitor design: first, variation of substituents on the naphthalene sulfonamide core allows improvements in anti-STAT activity and creates a more thorough understanding of anti-STAT SAR. Second, a novel approach involving hybrid sulfonamide–rhodium( ii ) conjugates tests our ability to use cooperative organic–inorganic binding for drug development, and to use SAR studies to inform metal conjugate design. Both approaches have produced compounds with improved binding potency. In vivo and in cellulo experiments further demonstrate that these approaches can also lead to improved activity in living cells, and that compound 3aa slows disease progression in a xenograft model of AML. 

   more » « less